Deutsche Bank Downgrades Genzyme (GENZ) to Hold; Risk/Reward Balanced

September 18, 2009 7:19 AM EDT Send to a Friend
Deutsche Bank downgrades Genzyme (Nasdaq: GENZ) to Hold from Buy. Price target $61.

Deutsche analyst says, "We upgraded GENZ shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login